Cui Dixin, Yu Sihan, Zhou Xin, Liu Ying, Gan Lu, Pan Yue, Zheng Liwei, Wan Mian
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Pediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Front Cell Dev Biol. 2021 May 19;9:666186. doi: 10.3389/fcell.2021.666186. eCollection 2021.
Dental caries and trauma always lead to pulp necrosis and subsequent root development arrest of young permanent teeth. The traditional treatment, apexification, with the absence of further root formation, results in abnormal root morphology and compromises long-term prognosis. Regeneration endodontics procedures (REPs) have been developed and considered as an alternative strategy for management of immature permanent teeth with pulpal necrosis, including cell-free and cell-based REPs. Cell-free REPs, including revascularization and cell homing with molecules recruiting endogenous mesenchymal stem cells (MSCs), have been widely applied in clinical treatment, showing optimistic periapical lesion healing and continued root development. However, the regenerated pulp-dentin complex is still absent in these cases. Dental MSCs, as one of the essentials of tissue engineering, are vital seed cells in regenerative medicine. Dental MSC-based REPs have presented promising potential with pulp-dentin regeneration in large animal studies and clinical trials via cell transplantation. In the present review, we summarize current understanding of the biological basis of clinical treatments for immature necrotic permanent teeth and the roles of dental MSCs during this process and update the progress of MSC-based REPs in the administration of immature necrotic permanent teeth.
龋齿和外伤总是会导致年轻恒牙的牙髓坏死以及随后的牙根发育停滞。传统的根尖诱导成形术,由于缺乏进一步的牙根形成,会导致牙根形态异常并影响长期预后。再生牙髓治疗程序(REPs)已被开发出来,并被视为治疗牙髓坏死的未成熟恒牙的一种替代策略,包括无细胞和基于细胞的REPs。无细胞REPs,包括血管再生和利用招募内源性间充质干细胞(MSCs)的分子进行细胞归巢,已广泛应用于临床治疗,显示出根尖周病变愈合和牙根持续发育的乐观效果。然而,在这些病例中仍然缺乏再生的牙髓-牙本质复合体。牙源性间充质干细胞作为组织工程的要素之一,是再生医学中至关重要的种子细胞。基于牙源性间充质干细胞的REPs在大型动物研究和临床试验中通过细胞移植实现牙髓-牙本质再生方面展现出了有前景的潜力。在本综述中,我们总结了目前对未成熟坏死恒牙临床治疗生物学基础的理解以及牙源性间充质干细胞在此过程中的作用,并更新了基于间充质干细胞的REPs在治疗未成熟坏死恒牙方面的进展。